Shelley Hwang

Dr. Shelley Hwang, MD, MPH, MBA is the Mary and Deryl Hart Distinguished Professor of Surgical Oncology and Radiology, Vice Chair of Research for the Duke Department of Surgery, and Lead of the Breast Oncology Program at the Duke University Comprehensive Cancer Center. Her research focus includes breast cancer prevention, identifying less invasive treatments for early-stage breast cancers including ductal carcinoma in situ (DCIS), and addressing and mitigating health care disparities in breast cancer.

Dr. Hwang is an experienced clinical trialist with an interest in both the biology and treatment of early-stage breast cancer. She has led large, multidisciplinary clinical teams of breast cancer providers, advocates, and researchers in international projects to improve treatment and outcomes for breast cancer. Dr. Hwang is a nationally recognized figure in pre-invasive disease and leads collaborative efforts on this topic including the Cancer Research UK “Precision” study and the randomized trial of DCIS active surveillance known as COMET. She is the Principal Investigator of the Duke Precancer Atlas Project, where the team seeks to perform multi-omic characterization of breast precancers as part of the Human Tumor Atlas Network (HTAN). She also co-chairs the NCI Breast Cancer Steering Committee and is a member of the National Comprehensive Cancer Network Screening Guidelines Committee.

‍